Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Membrane localization of the Repeats-in-Toxin (RTX) Leukotoxin (LtxA) produced by Aggregatibacter actinomycetemcomitans.

Brown AC, Boesze-Battaglia K, Balashova NV, Mas Gómez N, Speicher K, Tang HY, Duszyk ME, Lally ET.

PLoS One. 2018 Oct 18;13(10):e0205871. doi: 10.1371/journal.pone.0205871. eCollection 2018.

2.

Aggregatibacter actinomycetemcomitans Leukotoxin Is Delivered to Host Cells in an LFA-1-Indepdendent Manner When Associated with Outer Membrane Vesicles.

Nice JB, Balashova NV, Kachlany SC, Koufos E, Krueger E, Lally ET, Brown AC.

Toxins (Basel). 2018 Oct 13;10(10). pii: E414. doi: 10.3390/toxins10100414.

3.

In vitro characterization of biofilms formed by Kingella kingae.

Kaplan JB, Sampathkumar V, Bendaoud M, Giannakakis AK, Lally ET, Balashova NV.

Mol Oral Microbiol. 2017 Aug;32(4):341-353. doi: 10.1111/omi.12176. Epub 2016 Dec 12.

4.

Inhibition of LtxA toxicity by blocking cholesterol binding with peptides.

Brown AC, Koufos E, Balashova NV, Boesze-Battaglia K, Lally ET.

Mol Oral Microbiol. 2016 Feb;31(1):94-105. doi: 10.1111/omi.12133. Epub 2015 Oct 12.

5.

Major intercontinentally distributed sequence types of Kingella kingae and development of a rapid molecular typing tool.

Basmaci R, Bidet P, Yagupsky P, Muñoz-Almagro C, Balashova NV, Doit C, Bonacorsi S.

J Clin Microbiol. 2014 Nov;52(11):3890-7. doi: 10.1128/JCM.01609-14. Epub 2014 Aug 20.

6.

Genotyping, local prevalence and international dissemination of β-lactamase-producing Kingella kingae strains.

Basmaci R, Bonacorsi S, Bidet P, Balashova NV, Lau J, Muñoz-Almagro C, Gene A, Yagupsky P.

Clin Microbiol Infect. 2014 Nov;20(11):O811-7. doi: 10.1111/1469-0691.12648. Epub 2014 Jun 14.

7.

RTX toxin plays a key role in Kingella kingae virulence in an infant rat model.

Chang DW, Nudell YA, Lau J, Zakharian E, Balashova NV.

Infect Immun. 2014 Jun;82(6):2318-28. doi: 10.1128/IAI.01636-14. Epub 2014 Mar 24.

8.

Characterization of TEM-1 β-Lactamase-Producing Kingella kingae Clinical Isolates.

Banerjee A, Kaplan JB, Soherwardy A, Nudell Y, Mackenzie GA, Johnson S, Balashova NV.

Antimicrob Agents Chemother. 2013 Sep;57(9):4300-4306. doi: 10.1128/AAC.00318-13. Epub 2013 Jun 24.

9.

Aggregatibacter actinomycetemcomitans leukotoxin utilizes a cholesterol recognition/amino acid consensus site for membrane association.

Brown AC, Balashova NV, Epand RM, Epand RF, Bragin A, Kachlany SC, Walters MJ, Du Y, Boesze-Battaglia K, Lally ET.

J Biol Chem. 2013 Aug 9;288(32):23607-21. doi: 10.1074/jbc.M113.486654. Epub 2013 Jun 21.

10.

Genome sequence of Kingella kingae septic arthritis isolate PYKK081.

Kaplan JB, Lo C, Xie G, Johnson SL, Chain PS, Donnelly R, Kachlany SC, Balashova NV.

J Bacteriol. 2012 Jun;194(11):3017. doi: 10.1128/JB.00421-12.

11.

Gangliosides block Aggregatibacter Actinomycetemcomitans leukotoxin (LtxA)-mediated hemolysis.

Forman MS, Nishikubo JB, Han RK, Le A, Balashova NV, Kachlany SC.

Toxins (Basel). 2010 Dec;2(12):2824-36. doi: 10.3390/toxins2122824. Epub 2010 Dec 14.

12.

Broad-spectrum biofilm inhibition by Kingella kingae exopolysaccharide.

Bendaoud M, Vinogradov E, Balashova NV, Kadouri DE, Kachlany SC, Kaplan JB.

J Bacteriol. 2011 Aug;193(15):3879-86. doi: 10.1128/JB.00311-11. Epub 2011 May 20.

13.

Cytotoxic effects of Kingella kingae outer membrane vesicles on human cells.

Maldonado R, Wei R, Kachlany SC, Kazi M, Balashova NV.

Microb Pathog. 2011 Jul-Aug;51(1-2):22-30. doi: 10.1016/j.micpath.2011.03.005. Epub 2011 Apr 2.

14.

Scleroplasty in progressive myopia.

Balashova NV, Ghaffariyeh A, Honarpisheh N.

Eye (Lond). 2010 Jul;24(7):1303. doi: 10.1038/eye.2009.322. Epub 2010 Jan 15. No abstract available.

PMID:
20075973
15.

Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells.

Kachlany SC, Schwartz AB, Balashova NV, Hioe CE, Tuen M, Le A, Kaur M, Mei Y, Rao J.

Leuk Res. 2010 Jun;34(6):777-85. doi: 10.1016/j.leukres.2009.08.022. Epub 2009 Sep 10.

16.

Aggregatibacter actinomycetemcomitans LtxC is required for leukotoxin activity and initial interaction between toxin and host cells.

Balashova NV, Shah C, Patel JK, Megalla S, Kachlany SC.

Gene. 2009 Aug 15;443(1-2):42-7. doi: 10.1016/j.gene.2009.05.002. Epub 2009 May 18.

PMID:
19450669
17.

A bioluminescent HL-60 cell line to assay anti-leukaemia therapeutics under physiological conditions.

Isaza MP, Chau JT, Le A, Balashova NV, Patel JK, Salerno E, Crosby JA, O'Connor A, Kachlany SC.

Luminescence. 2008 Jan-Feb;23(1):17-21. doi: 10.1002/bio.1010.

PMID:
18167057
18.

Interaction between leukotoxin and Cu,Zn superoxide dismutase in Aggregatibacter actinomycetemcomitans.

Balashova NV, Park DH, Patel JK, Figurski DH, Kachlany SC.

Infect Immun. 2007 Sep;75(9):4490-7. Epub 2007 Jul 16.

19.

Human CD18 is the functional receptor for Aggregatibacter actinomycetemcomitans leukotoxin.

Dileepan T, Kachlany SC, Balashova NV, Patel J, Maheswaran SK.

Infect Immun. 2007 Oct;75(10):4851-6. Epub 2007 Jul 16.

20.

Regulation of Aggregatibacter (Actinobacillus) actinomycetemcomitans leukotoxin secretion by iron.

Balashova NV, Diaz R, Balashov SV, Crosby JA, Kachlany SC.

J Bacteriol. 2006 Dec;188(24):8658-61. Epub 2006 Oct 13.

21.

[The epidemiological and clinicoimmunological aspects of the outburst of trichinosis in the Krymsky District of the Krasnodar Territory].

Tverdokhlebova TI, Vaserin IuI, Mkrtchan MO, Balashova NV, Prokopova LV, Sapunov AIa, Popov MA, Nagornyĭ SA, Tsybina TN, Iakovlev NS.

Med Parazitol (Mosk). 2006 Jan-Mar;(1):21-5. Russian.

PMID:
16562745
22.

Leukotoxin confers beta-hemolytic activity to Actinobacillus actinomycetemcomitans.

Balashova NV, Crosby JA, Al Ghofaily L, Kachlany SC.

Infect Immun. 2006 Apr;74(4):2015-21.

23.

Characterization of leukotoxin from a clinical strain of Actinobacillus actinomycetemcomitans.

Diaz R, Ghofaily LA, Patel J, Balashova NV, Freitas AC, Labib I, Kachlany SC.

Microb Pathog. 2006 Feb;40(2):48-55. Epub 2006 Jan 18.

PMID:
16414241
24.

[Syndrome of non-thyroid pathology in patients with cardiovascular diseases (review)].

Ametov AS, Balashova NV, Giliarevskiĭ SR.

Ter Arkh. 2003;75(10):25-30. Review. Russian. No abstract available.

PMID:
14669601
26.

[Genetic control of naphthalene biodegradation by a strain of Pseudomonas sp. 8909N].

Kosheleva IA, Sokolov SL, Balashova NV, Filonov AE, Meleshko EI, Gaiazov RR, Boronin AM.

Genetika. 1997 Jun;33(6):762-8. Russian.

PMID:
9289413
27.

[Ocular vasocompression in progressive myopia and the follow-up of its efficacy (preliminary report)].

Ivashina AI, Mikhaĭlova GD, Balashova NV, Ioffe DI, Nikitin IuM.

Vestn Oftalmol. 1988 Sep-Oct;104(5):31-4. Russian. No abstract available.

PMID:
3065995

Supplemental Content

Loading ...
Support Center